Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN.
Slot MIE, Urquijo Castro MF, Winter-van Rossum I, van Hell HH, Dwyer D, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj BY, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Kirschner M; PSYSCAN Consortium; Fleischhacker WW, McGuire P, Koutsouleris N, Kahn RS. Slot MIE, et al. Among authors: weiser m. Schizophrenia (Heidelb). 2024 Oct 7;10(1):89. doi: 10.1038/s41537-024-00505-w. Schizophrenia (Heidelb). 2024. PMID: 39375356 Free PMC article.
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.
Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Bressan R, Kwon JS, Weiser M, Mizrahi R, Sachs G, Maatz A, Kahn R, McGuire P; PSYSCAN Consortium. Tognin S, et al. Among authors: weiser m. Schizophr Bull. 2020 Feb 26;46(2):432-441. doi: 10.1093/schbul/sbz067. Schizophr Bull. 2020. PMID: 31424555 Free PMC article.
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.
Dazzan P, Lawrence AJ, Reinders AATS, Egerton A, van Haren NEM, Merritt K, Barker GJ, Perez-Iglesias R, Sendt KV, Demjaha A, Nam KW, Sommer IE, Pantelis C, Wolfgang Fleischhacker W, van Rossum IW, Galderisi S, Mucci A, Drake R, Lewis S, Weiser M, Martinez Diaz-Caneja CM, Janssen J, Diaz-Marsa M, Rodríguez-Jimenez R, Arango C, Baandrup L, Broberg B, Rostrup E, Ebdrup BH, Glenthøj B, Kahn RS, McGuire P; OPTiMiSE study group. Dazzan P, et al. Among authors: weiser m. Schizophr Bull. 2021 Mar 16;47(2):444-455. doi: 10.1093/schbul/sbaa115. Schizophr Bull. 2021. PMID: 33057670 Free PMC article. Clinical Trial.
Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study.
Kerins S, Nottage J, Salazar de Pablo G, Kempton MJ, Tognin S, Niemann DH, de Haan L, van Amelsvoort T, Kwon JS, Nelson B, Mizrahi R, McGuire P, Fusar-Poli P; PSYSCAN Consortium. Kerins S, et al. Front Psychiatry. 2022 Mar 16;13:828376. doi: 10.3389/fpsyt.2022.828376. eCollection 2022. Front Psychiatry. 2022. PMID: 35370849 Free PMC article.
Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies.
Worker A, Berthert P, Lawrence AJ, Kia SM, Arango C, Dinga R, Galderisi S, Glenthøj B, Kahn RS, Leslie A, Murray RM, Pariante CM, Pantelis C, Weiser M, Winter-van Rossum I, McGuire P, Dazzan P, Marquand AF. Worker A, et al. Among authors: weiser m. Transl Psychiatry. 2023 Dec 2;13(1):373. doi: 10.1038/s41398-023-02661-6. Transl Psychiatry. 2023. PMID: 38042835 Free PMC article.
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group. Kahn RS, et al. Among authors: weiser m. Lancet Psychiatry. 2018 Oct;5(10):797-807. doi: 10.1016/S2215-0366(18)30252-9. Epub 2018 Aug 13. Lancet Psychiatry. 2018. PMID: 30115598 Free article. Clinical Trial.
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS. Davidson M, et al. Among authors: weiser m. Am J Psychiatry. 2009 Jun;166(6):675-82. doi: 10.1176/appi.ajp.2008.08060806. Epub 2009 Apr 15. Am J Psychiatry. 2009. PMID: 19369319 Clinical Trial.
998 results